|
| 37233722 | Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI) | | 2023 |
| 37186262 | MCAM+CD161- Th17 Subset Expressing CD83 Enhances Tc17 Response in Psoriasis. | | 2023 |
| 36527156 | Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study. | | 2022 |
| 34448173 | Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study. | Rheumatol Ther | 2021 |
| 33846499 | Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis. | Scientific Reports | 2021 |
| 32770199 | Inhibition of hepatocyte growth factor/c-Met signalling abrogates joint destruction by suppressing monocyte migration in rheumatoid arthritis. | Rheumatology | 2021 |
| 33265990 | Role of Cytokines in EGPA and the Possibility of Treatment with an Anti-IL-5 Antibody. | Journal of Clinical Medicine | 2020 |
| 32637608 | Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. | Sci Adv | 2020 |
| 32518591 | Seven-day services in surgery and the "weekend effect" at a Japanese teaching hospital: a retrospective cohort study. | Patient Safety in Surgery | 2020 |
| 32896992 | Weekly split-dose regimen for oral methotrexate reduced polyglutamation in red blood cells in patients with rheumatoid arthritis compared with single-dose regimen: Results from a multicentered randomized control trial. | International Journal of Rheumatic Diseases | 2020 |
| 31181818 | Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. | Cells | 2019 |
| 31853259 | Serum anti-Müllerian hormone levels in women with rheumatoid arthritis during tumor necrosis factor-α inhibitor treatment: Exploratory research. | Obstetric Medicine | 2019 |
| 30634456 | A Disintegrin and Metalloprotease 15 is Expressed on Rheumatoid Arthritis Synovial Tissue Endothelial Cells and may Mediate Angiogenesis. | Cells | 2019 |
| 29411180 | ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease. | Clinical Rheumatology | 2018 |
| 30071898 | ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesion. | | 2018 |
| 30185359 | A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment. | | 2018 |
| 29525842 | Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease. | Clinical Rheumatology | 2018 |
| 29657870 | Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression? | | 2018 |
| 27846745 | A disintegrin and metalloproteinase (ADAM)-10 as a predictive factor for tocilizumab effectiveness in rheumatoid arthritis. | Modern Rheumatology | 2017 |
| 28420837 | Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment. | Internal Medicine | 2017 |
| 28794381 | Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment. | Internal Medicine | 2017 |
| 29021442 | The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis. | Internal Medicine | 2017 |
| 29290847 | Predictor of the Simplified Disease Activity Index 50 (SDAI 50) at Month 3 of bDMARD Treatment in Patients with Long-Established Rheumatoid Arthritis. | Open Rheumatology Journal | 2017 |
| 27629950 | Comparative Study of Infliximab Therapy and Methotrexate Monotherapy to Improve the Clinical Effect in Rheumatoid Arthritis Patients. | Internal Medicine | 2016 |
| 27085681 | Clinical effects of tocilizumab on cytokines and immunological factors in patients with rheumatoid arthritis. | International Immunopharmacology | 2016 |
| 26819561 | Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases. | Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | 2016 |
| 26698929 | Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from the ENCOURAGE study, a prospective, international, multicenter randomized study. | Modern Rheumatology | 2016 |
| 24506660 | A case of Degos disease: demonstration of C5b-9-mediated vascular injury. | Modern Rheumatology | 2015 |
| 25796462 | A disintegrin and metalloprotease-10 is correlated with disease activity and mediates monocyte migration and adhesion in rheumatoid arthritis. | | 2015 |
| 25834203 | Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study. | Journal of Rheumatology | 2015 |
| 26056606 | Influence of renal complications on the efficacy and adverse events of tacrolimus combination therapy in patients with systemic lupus erythematosus (SLE) during a maintenance phase: a single-centre, prospective study. | Lupus Science and Medicine | 2015 |
| 26312106 | Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State. | Open Rheumatology Journal | 2015 |
| 26328658 | Therapeutic Efficacy of Leukocytapheresis in a Pregnant Woman with Refractory Adult-onset Still's Disease. | Internal Medicine | 2015 |
| 24670129 | Efficacy of anti-ribosomal P protein antibody testing for diagnosis of systemic lupus erythematosus. | Modern Rheumatology | 2014 |
| 25598752 | Reduction of Serum ADAM17 Level Accompanied with Decreased Cytokines after Abatacept Therapy in Patients with Rheumatoid Arthritis. | International Journal of Biomedical Science (discontinued) | 2014 |
| 27708901 | Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone. | | 2014 |
| 27790035 | Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis. | Open Access Rheumatology: Research and Reviews | 2014 |
| 23670804 | Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis. | Rheumatology International | 2014 |
| 23355786 | Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis. | Journal of Multidisciplinary Healthcare | 2013 |
| 22990336 | Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents. | Modern Rheumatology | 2013 |
| 22975754 | A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study. | Annals of the Rheumatic Diseases | 2013 |
| 23961670 | [Adalimumab]. | Nippon rinsho. Japanese journal of clinical medicine | 2013 |
| 21607712 | Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity. | Modern Rheumatology | 2012 |
| 22413501 | [How to use of the psychotropic drug in rheumatic disease]. | Nippon rinsho. Japanese journal of clinical medicine | 2012 |
| 22322207 | Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome. | Clinical Rheumatology | 2012 |
| 21572151 | Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study. | Journal of Rheumatology | 2011 |
| 27789999 | Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis. | Open Access Rheumatology: Research and Reviews | 2011 |
| 21256458 | Synergistic induction of CX3CL1 by interleukin-1β and interferon-γ in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways. | | 2011 |
| 22046508 | Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases. | | 2010 |
| 27789995 | Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis. | Open Access Rheumatology: Research and Reviews | 2010 |